200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 629-01-6

629-01-6

629-01-6 | N-OCTANAMIDE

CAS No: 629-01-6 Catalog No: AG003T9D MDL No:MFCD00191675

Product Description

Catalog Number:
AG003T9D
Chemical Name:
N-OCTANAMIDE
CAS Number:
629-01-6
Molecular Formula:
C8H17NO
Molecular Weight:
143.2267
MDL Number:
MFCD00191675
IUPAC Name:
octanamide
InChI:
InChI=1S/C8H17NO/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H2,9,10)
InChI Key:
LTHCSWBWNVGEFE-UHFFFAOYSA-N
SMILES:
CCCCCCCC(=O)N
EC Number:
211-066-7
UNII:
1X5804D710
NSC Number:
5515

Properties

Complexity:
91.3  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
143.131g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
143.23g/mol
Monoisotopic Mass:
143.131g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
43.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.4  

Literature

Title Journal
Aliskiren: An orally active renin inhibitor. Journal of pharmacy & bioallied sciences 20110101
Role of aliskiren in blood pressure control and renoprotection. International journal of nephrology and renovascular disease 20110101
Biocatalytic amidation of carboxylic acids and their antinemic activity. Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20100401
N-octanoyl dopamine, a non-hemodyanic dopamine derivative, for cell protection during hypothermic organ preservation. PloS one 20100101
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination. Vascular health and risk management 20100101
Chemical Investigation of Crataeva nurvala Buch. Ham. Fruits. Indian journal of pharmaceutical sciences 20090101
Cytotoxicity and acid ceramidase inhibitory activity of 2-substituted aminoethanol amides. Chemistry and physics of lipids 20081101
Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease. Journal of human hypertension 20080501
Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid. Life sciences 20080130
Amination of n-hexanol in supercritical water. Environmental science & technology 20051215
Highly selective disaccharide recognition by a tricyclic octaamide cage. Angewandte Chemie (International ed. in English) 20021104
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension (Dallas, Tex. : 1979) 20020101
New efficient calixarene amide ionophores for the selective removal of strontium ion from nuclear waste: synthesis, complexation, and extraction properties. Journal of the American Chemical Society 20011212
Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. CNS drug reviews 20010101

© 2019 Angene International Limited. All rights Reserved.